HIRO TT: the research confirms its effectiveness

20 July 2018 - Research -

"Dual and parallel action" is not just a slogan for HIRO TT, but the trait which characterises its uniqueness, contributing to make it a highly effective therapeutic strategy for treating painful pathologies of the musculoskeletal system. Based on the principle of thermal exchange, which allows an early intervention even for the most acute pathologies, by combining the pulsed Nd:YAG laser source to a cooling system which lowers the temperature of the skin and of the underlying tissues (SmartCooler), HIRO TT offers significant and long-lasting therapeutic results without having to compromise on safety.

The scientific research

This is confirmed by the 100 patients chosen as a panel for a scientific research - “Pulsed Nd:YAG laser and thermal exchange: a new therapeutic strategy in pain manegement. Experience on 100 patients” (S. Germano, D. Broglia, F. Salvò, E. Firpo, M. Mezzalira) - aimed at evaluating the effect of the "made in ASA" therapeutic strategy on neuromuscular and bone or joint disorders. Published in the seventeenth edition of Energy For Health, the study evaluated the results of applying HIRO TT for some specific issues (trauma, oedema, contractures, tendinopathies, arthritis and joint diseases) taking into consideration two parameters: the VAS scale and the functional changes.

After having submitted a sample of patients to ultrasound and to magnetic resonance imaging before and after treatment, the clinical evidence has in fact shown that its application in physiotherapy and pain management provides an evident pain reduction and promising preliminary results in terms of oedema and decrease in inflammation.

Results which are the outcome of the use of the SmartCooler, which enables making the most of the HILT® pulse, allowing to convey more photons faster and more in depth. All this whilst providing comfort to the patient during treatment even for the most acute pathologies and very sensitive subjects.

You might also be interested in ...

See all articles

M6 laser & pain management
News - 21/01/2021
“Following our direct experience, we confirm the conclusions reached in America in relation to the value of MLS® for treating interstitial pneumonia caused by the virus. Its action consists in...
Laser and Magnetotherapy effective in physical rehabilitation post interstitial pneumonia (or coronavirus pneumonia)
News - 03/08/2020
The "Physical rehabilitation of patients with pneumonia associated with coronavirus infection (COVID-19)" manual released by the Ministry of Science and Higher Education of the Russian Federation, in...
Parmitano speaking about Xenogriss - Beyond Mission
News - 03/08/2020
It’s time for first conclusions for Xenogriss, included in the scientific experiments carried out on the International Space Station during the Beyond mission led by Luca Parmitano, the Italian...
Press - 03/05/2021
Every week, approximately 6 out of 10 Italians have to deal with back pain which limits their daily activities: Laser Therapy (MLS® and Hilterapia®) combined with postural gymnastics is successfully...
Press - 21/04/2021
The financial section of the daily newspaper “Il Giornale di Vicenza” devotes an extensive focus to the valuable results chalked up by ASA for the first quarter of 2021.
ASA laser device manufacturing
News - 20/04/2021
Breaking through 3 million euro in turnover, ASA marks an excellent result for the first 3 months of activity of 2021 thanks to a significant increase in the sales of its therapies for the human and...